Saint Luke's cardiologist leads trial to see if diabetes drug can prevent serious Covid-19 complications
April 25, 2020 at 11:23 AM EDT
A cardiologist with the Saint Luke's Mid America Heart Institute is the principal investigator in a trial to see if a diabetes drug could prevent deadly heart and kidney complications in Covid-19 patients.
